This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 20-26 August and includes updates on avian influenza, botulism, autochthonous dengue, Legionnaires’

This document provides an update on the safety of substances of human origin (SoHO) in relation to COVID-19. It reassesses the risk and proposes revised

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 13-19 August and includes updates on avian influenza A(H5N6), avian influenza A(H9N2),

In 2023, after several months of very low rates of infection, coronavirus disease 2019 (COVID-19) transmission has started to increase in some EU/EEA countries.

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 6 – 12 August 2023 and includes updates on measles, COVID-19, swine

This report summarises results from an analysis conducted by ECDC and Eurofound to understand the impact of selected NPIs introduced from 2020 to 2022 in

The new joint report by ECDC and Eurofound concludes that adult work-life balance was significantly affected by measures such as stay-at-home orders and recommendations.

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 30 July – 5 August 2023 and includes updates on avian influenza,

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 23-29 July 2023 and includes updates on cholera, MERS-CoV, Chikungunya, dengue, COVID-19,

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 16-22 July 2023 and includes updates on avian influenza, Echovirus 11, COVID-19,

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 9-15 July 2023 and includes updates on avian influenza, West Nile virus,

Antiviral drugs and monoclonal antibodies (mAbs), administered either separately or as combination therapy ‘cocktails’, have provided a valuable tool for fighting COVID-19. Surveillance data, coupled